Tobacco control represents one of the major public health successes of the last half century. Since the early reports establishing the causal role of tobacco in heart disease and cancer, substantial efforts to reduce cigarette smoking have played an important role in the reduction in the incident rates of cardiovascular disease and associated mortality in the Western world. Given the global spread of cardiometabolic risk and high rate of cigarette smoking in developing nations, there continues to be a major need to target tobacco cessation, which represents a cornerstone of worldwide efforts to reduce cardiovascular mortality by 25% by 2025.
A number of reports have emerged that associate marijuana use with incident cardiovascular events. 1, 2 The relative importance of these reports has been uncertain as the association between marijuana and cardiovascular disease has not been well characterized. Globally, there are more than 180 million marijuana users, while the estimated annual prevalence in North Americans aged 15-64 years is greater than 11%. 3 Efforts to legalize use of marijuana for medicinal purpose have gained increasing attention, with additional support for the legalization of marijuana for recreational use. Such initiatives underscore the belief that marijuana, as an illicit substance, lacks harmful effects on health in comparison to other banned substances. As these legislative efforts have the potential to widely expand the use of marijuana, it would seem timely that a clear understanding of the effects on cardiovascular health was established.
In this issue of the Journal, Yankey and colleagues investigated the relationship between marijuana use and cardiovascular death in 1213 individuals who responded to questions regarding marijuana use in the National Health and Nutrition Examination Survey (NHANES). 4 Data from this survey was linked to public use linked mortality files. Of the total 1213 individuals, more than 50% identified as marijuana users with a mean duration of 11.5 years. The survey findings revealed that marijuana users demonstrated an increase in risk of all-cause mortality. In particular, marijuana users had a greater than three-fold increase in risk of death from hypertension, even after adjustment for cigarette smoking and other cardiovascular risk factors, including hypertension. Subsequent analysis revealed an increase in risk for each year of marijuana use, which just met the conventional criteria for statistical significance. Of interest, risk of death attributed to either heart disease or cerebrovascular disease was not increased in marijuana users.
These are interesting observations that suggest there may be an association between increasing duration of marijuana use and death due to hypertension. This must be balanced against the limitations of this analysis, including: the relatively small cohort studied; inherent bias related to inclusion of only participants that responded to the question regarding marijuana; and lack of any attempt to quantify marijuana use beyond calculating the duration between estimated start of use and the year of the survey. Nevertheless, the findings do suggest that we need to better understand the potential implications of marijuana on cardiovascular health.
This data contributes to a background literature with multiple reports of an association between marijuana use and acute coronary syndromes, particularly those in younger men without major cardiovascular risk factors and induced following strenuous physical exercise. 1,2 A number of potential mechanisms have been reported to link marijuana and myocardial infarction, including coronary vasospasm, heightened sympathetic activity, endothelial damage, elevated carboxyhemoglobin levels, and development of a prothrombotic state. 3 Autonomic dysfunction is likely to underscore potential links between marijuana and arrhythmia. 3 In addition, marijuana use has been temporally associated with the development of Takotsubo South Australian Health and Medical Research Institute, University of Adelaide, Australia cardiomyopathy, the so-called ''broken heart syndrome,'' which may reflect the association with increased sympathetic tone. 3 While not well studied, it is likely that activation of inflammatory and oxidative pathways, implicated in cardiovascular disease, is likely to be present in the setting of marijuana use. To balance this, there are potential reports of fewer cardiometabolic risk factors, such as insulin resistance and diabetes, in marijuana users, although these are not well characterized by vigorous statistical approaches.
With the likely increase in marijuana use that is expected to follow the legalization of both recreational and medicinal use, a greater understanding of the health consequences is urgently needed to better inform public health programs. Further study will be required to determine how marijuana modulates factors implicated in the progression of cardiovascular disease and its adverse clinical outcomes. Over the course of the last century, the clinical demographics associated with incident cardiovascular disease have evolved, as evidenced by the proliferation of abdominal obesity and associated insulin resistance. For now, it remains uncertain whether marijuana use will become one of the new factors associated with driving a resurgence of cardiovascular risk: however, it is time to find out.
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